PGGM Investments reduced its stake in Clorox Company (The) (NYSE:CLX) by 1.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 108,178 shares of the company’s stock after selling 1,638 shares during the period. PGGM Investments owned approximately 0.08% of Clorox Company (The) worth $14,414,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Jacobi Capital Management LLC boosted its position in Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock valued at $172,000 after buying an additional 4 shares during the period. Bridgeworth LLC raised its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock valued at $252,000 after buying an additional 5 shares in the last quarter. Valley National Advisers Inc. raised its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. raised its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. Finally, Wade G W & Inc. raised its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Wade G W & Inc. now owns 3,173 shares of the company’s stock valued at $428,000 after buying an additional 8 shares in the last quarter. Institutional investors own 69.83% of the company’s stock.
Shares of Clorox Company (NYSE:CLX) opened at 137.73 on Friday. The stock’s 50 day moving average price is $133.55 and its 200-day moving average price is $134.12. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The stock has a market cap of $17.78 billion, a price-to-earnings ratio of 25.82 and a beta of 0.40.
Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the previous year, the business earned $1.30 EPS. Clorox Company (The)’s revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Company will post $5.67 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “PGGM Investments Lowers Stake in Clorox Company (The) (CLX)” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://stocknewstimes.com/2017/08/19/pggm-investments-reduces-stake-in-clorox-company-the-clx-updated-updated.html.
Several analysts have issued reports on CLX shares. Vetr raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price for the company in a research note on Monday, April 24th. Royal Bank Of Canada set a $115.00 target price on Clorox Company (The) and gave the stock a “hold” rating in a research note on Monday, April 24th. Jefferies Group LLC set a $138.00 target price on Clorox Company (The) and gave the stock a “hold” rating in a research note on Wednesday, May 3rd. BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Finally, UBS AG reaffirmed a “sell” rating and issued a $121.00 target price (up previously from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $129.05.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
